• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用经过验证的稳定性指示高效液相色谱法,对纳曲酮植入剂“生物相关性”体外释放测试的潜在介质进行表征。

Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method.

作者信息

Iyer Sunil S, Barr William H, Karnes H Thomas

机构信息

Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298-0533, USA.

出版信息

J Pharm Biomed Anal. 2007 Feb 19;43(3):845-53. doi: 10.1016/j.jpba.2006.08.023. Epub 2006 Oct 11.

DOI:10.1016/j.jpba.2006.08.023
PMID:17045445
Abstract

A variety of factors have been recognized that influence media optimization for drug release studies of implant dosage forms. Of primary importance is selection of a medium that physiologically mimics the milieu at the site of administration (a condition termed 'biorelevance'). We describe in this paper, the characterization of Hanks' balanced salts solution, with necessary modification, for application as a 'biorelevant' medium for in vitro release studies of a biodegradable, subcutaneous implant of naltrexone. A detailed investigation of changes in pH, osmolality and ultraviolet (UV) spectrum as a function of time and temperature was conducted. Variation in the parameters evaluated was found to be within acceptable limits. Validation of a simple and selective, high performance liquid chromatography (HPLC) assay method for naltrexone was carried out to evaluate stability. The calibration curves were linear from 0.16 to 20.00 microg ml(-1). Imprecision and inaccuracy were less than 2% and no interference was observed from degradation peaks. Stability studies of naltrexone indicated the media should be replaced every 7-8 days for real-time testing. This was applied to an investigation of in vitro drug release. The method has been proven to be suitable for investigation of naltrexone released from the implant.

摘要

人们已经认识到多种因素会影响植入剂剂型药物释放研究的介质优化。其中最重要的是选择一种能在生理上模拟给药部位环境的介质(这种情况称为“生物相关性”)。在本文中,我们描述了经过必要改良的汉克斯平衡盐溶液的特性,该溶液可作为生物可降解的纳曲酮皮下植入剂体外释放研究的“生物相关”介质。我们对pH值、渗透压和紫外光谱随时间和温度的变化进行了详细研究。结果发现,所评估参数的变化在可接受范围内。我们还对一种简单、选择性的纳曲酮高效液相色谱(HPLC)测定方法进行了验证,以评估其稳定性。校准曲线在0.16至20.00微克/毫升范围内呈线性。精密度和误差小于2%,未观察到降解峰产生干扰。纳曲酮的稳定性研究表明,为了进行实时测试,介质应每7 - 8天更换一次。这一方法已应用于体外药物释放研究。事实证明,该方法适用于研究从植入剂中释放的纳曲酮。

相似文献

1
Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method.采用经过验证的稳定性指示高效液相色谱法,对纳曲酮植入剂“生物相关性”体外释放测试的潜在介质进行表征。
J Pharm Biomed Anal. 2007 Feb 19;43(3):845-53. doi: 10.1016/j.jpba.2006.08.023. Epub 2006 Oct 11.
2
A 'biorelevant' system to investigate in vitro drug released from a naltrexone implant.一种用于研究纳曲酮植入剂体外药物释放的“生物相关”系统。
Int J Pharm. 2007 Aug 1;340(1-2):104-18. doi: 10.1016/j.ijpharm.2007.03.032. Epub 2007 Mar 30.
3
A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant.一种用于可生物降解纳曲酮植入剂体外药物释放加速测试的“生物相关性”方法。
Int J Pharm. 2007 Aug 1;340(1-2):119-25. doi: 10.1016/j.ijpharm.2007.03.033. Epub 2007 Mar 30.
4
Development and validation of a simple HPLC method for simultaneous in vitro determination of amoxicillin and metronidazole at single wavelength.一种用于在单波长下同时体外测定阿莫西林和甲硝唑的简单高效液相色谱法的开发与验证。
J Pharm Biomed Anal. 2007 Jan 4;43(1):325-9. doi: 10.1016/j.jpba.2006.06.002. Epub 2006 Jul 21.
5
Stability of oral liquid preparations of methylergometrine.麦角新碱口服液体制剂的稳定性
Pharmazie. 2006 Aug;61(8):701-5.
6
A stability-indicating HPLC method for medroxyprogesterone acetate in bulk drug and injection formulation.一种用于原料药和注射剂剂型中醋酸甲羟孕酮的稳定性指示高效液相色谱法。
J Pharm Biomed Anal. 2006 Mar 18;40(5):1068-72. doi: 10.1016/j.jpba.2005.08.028. Epub 2005 Oct 20.
7
Development and validation of reversed phase high performance liquid chromatography method for determination of dexpanthenol in pharmaceutical formulations.用于测定药物制剂中右泛醇的反相高效液相色谱法的建立与验证。
J Pharm Biomed Anal. 2007 Feb 19;43(3):983-8. doi: 10.1016/j.jpba.2006.09.021. Epub 2006 Oct 17.
8
Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.在辅料存在的情况下,用于定量测定含有八个降解峰的左甲状腺素的稳定性指示验证高效液相色谱法。
Int J Pharm. 2008 Aug 6;360(1-2):77-82. doi: 10.1016/j.ijpharm.2008.04.018. Epub 2008 Apr 20.
9
Development, validation and stability study of pediatric atenolol syrup.小儿阿替洛尔糖浆的研制、验证及稳定性研究
Pharmazie. 2007 Jul;62(7):519-21.
10
Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.一种用于分析热熔挤出剂型中盐酸异丙嗪的高效液相色谱法的开发与验证
Pharmazie. 2008 Aug;63(8):562-7.

引用本文的文献

1
Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.肌肉组织作为注射用储库型微球体外药物释放试验的替代物。
AAPS PharmSciTech. 2021 Mar 29;22(3):119. doi: 10.1208/s12249-021-01965-4.